Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F L Liew

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
JAMA Network Open|November 20, 2024
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer RiskXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
The Lancet. Rheumatology|July 28, 2021
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseasesJonathan S Hausmann, Kevin Kennedy, Julia F Simard, et al.
The Journal of Rheumatology|June 1, 2025
Development of the Australian Rheumatology Association Clinical Care Standard for the Diagnosis and Management of Rheumatoid Arthritis in AdultsMaria B Sukkar, Rosemary Ainley, Claire Barrett, et al.
Australasian Journal on Ageing|February 26, 2026
Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi StudyAmanda J Cross, Madiha Chaudhry, Darshna Goordeen, et al.
RMD Open|September 8, 2021
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveySebastian Eduardo Sattui, Jean W Liew, Kevin Kennedy, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
JAMA Network Open|November 20, 2024
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer RiskXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
The Lancet. Rheumatology|July 28, 2021
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseasesJonathan S Hausmann, Kevin Kennedy, Julia F Simard, et al.
The Journal of Rheumatology|June 1, 2025
Development of the Australian Rheumatology Association Clinical Care Standard for the Diagnosis and Management of Rheumatoid Arthritis in AdultsMaria B Sukkar, Rosemary Ainley, Claire Barrett, et al.
Australasian Journal on Ageing|February 26, 2026
Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi StudyAmanda J Cross, Madiha Chaudhry, Darshna Goordeen, et al.
RMD Open|September 8, 2021
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveySebastian Eduardo Sattui, Jean W Liew, Kevin Kennedy, et al.
Pageof 4